Mustang Bio is a clinical-stage biopharmaceutical company .
Mustang Bio has raised $8.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2025.
Mustang Bio's investors include Runway Growth Capital, National Institutes of Health, Horizon Technology Finance, California Institute for Regenerative Medicine.
Mustang Bio is headquartered in New York, United States.
Mustang Bio is a clinical-stage biopharmaceutical company .
Mustang Bio is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mustang Bio — Funding & Investors." VCBacked, February 6, 2025, https://www.vcbacked.co/company/mustang-bio. Accessed July 20, 2026.
VCBacked. (2025). Mustang Bio — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/mustang-bio
{{cite web |title=Mustang Bio — Funding & Investors |url=https://www.vcbacked.co/company/mustang-bio |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated